Midori Maekawa
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Midori Maekawa.
Nature | 1997
Masayoshi Uehata; Toshimasa Ishizaki; Hiroyuki Satoh; Takashi Ono; Toshio Kawahara; Tamami Morishita; Hiroki Tamakawa; Keiji Yamagami; Jun Inui; Midori Maekawa; Shuh Narumiya
Abnormal smooth-muscle contractility may be a major cause of disease states such as hypertension, and a smooth-muscle relaxant that modulates this process would be useful therapeutically. Smooth-muscle contraction is regulated by the cytosolic Ca2+ concentration and by the Ca2+ sensitivity of myofilaments: the former activates myosin light-chain kinase and the latter is achieved partly by inhibition of myosin phosphatase. The small GTPase Rho and its target, Rho-associated kinase, participate in this latter mechanism in vitro, but their participation has not been demonstrated in intact muscles. Here we show that a pyridine derivative, Y-27632, selectively inhibits smooth-muscle contraction by inhibiting Ca2+ sensitization. We identified the Y-27632 target as a Rho-associated protein kinase, p160ROCK. Y-27632 consistently suppresses Rho-induced, p160ROCK-mediated formation of stress fibres in cultured cells and dramatically corrects hypertension in several hypertensive rat models. Our findings indicate that p160ROCK-mediated Ca2+ sensitization is involved in the pathophysiology of hypertension and suggest that compounds that inhibit this process might be useful therapeutically.
The EMBO Journal | 1996
Toshimasa Ishizaki; Midori Maekawa; Kazuko Fujisawa; Katsuya Okawa; Akihiro Iwamatsu; Akiko Fujita; Yuji Saito; Akira Kakizuka; Narito Morii; Shuh Narumiya
The small GTP‐binding protein Rho functions as a molecular switch in the formation of focal adhesions and stress fibers, cytokinesis and transcriptional activation. The biochemical mechanism underlying these actions remains unknown. Using a ligand overlay assay, we purified a 160 kDa platelet protein that bound specifically to GTP‐bound Rho. This protein, p160, underwent autophosphorylation at its serine and threonine residues and showed the kinase activity to exogenous substrates. Both activities were enhanced by the addition of GTP‐bound Rho. A cDNA encoding p160 coded for a 1354 amino acid protein. This protein has a Ser/Thr kinase domain in its N‐terminus, followed by a coiled‐coil structure approximately 600 amino acids long, and a cysteine‐rich zinc finger‐like motif and a pleckstrin homology region in the C‐terminus. The N‐terminus region including a kinase domain and a part of coiled‐coil structure showed strong homology to myotonic dystrophy kinase over 500 residues. When co‐expressed with RhoA in COS cells, p160 was co‐precipitated with the expressed Rho and its kinase activity was activated, indicating that p160 can associate physically and functionally with Rho both in vitro and in vivo.
FEBS Letters | 1997
Toshimasa Ishizaki; Mamoru Naito; Kazuko Fujisawa; Midori Maekawa; Yuji Saito; Shuh Narumiya
© 1997 Federation of European Biochemical Societies.
Neuron | 2000
Haruhiko Bito; Tomoyuki Furuyashiki; Hisamitsu Ishihara; Yoshikazu Shibasaki; Kazumasa Ohashi; Kensaku Mizuno; Midori Maekawa; Toshimasa Ishizaki; Shuh Narumiya
We tested the contribution of the small GTPase Rho and its downstream target p160ROCK during the early stages of axon formation in cultured cerebellar granule neurons. p160ROCK inhibition, presumably by reducing the stability of the cortical actin network, triggered immediate outgrowth of membrane ruffles and filopodia, followed by the generation of initial growth cone-ike membrane domains from which axonal processes arose. Furthermore, a potentiation in both the size and the motility of growth cones was evident, though the overall axon elongation rate remained stable. Conversely, overexpression of dominant active forms of Rho or ROCK was suggested to prevent initiation of axon outgrowth. Taken together, our data indicate a novel role for the Rho/ROCK pathway as a gate critical for the initiation of axon outgrowth and the control of growth cone dynamics.
Virology | 1991
Yoshiharu Matsuura; Midori Maekawa; Seisuke Hattori; Nobuko Ikegam; Akio Hayashi; Shudo Yamazaki; Chiharu Morita; Yutaka Takebe
We have constructed the recombinant baculovirus which expresses the human immunodeficiency virus type 1 negative factor (nef) gene. Spodoptera frugiperda cells infected with the recombinant virus produced a 27-kDa protein which reacted with rabbit antisera raised against a carboxy-terminal synthetic peptide of the Nef protein by immunoblot analysis. Labeling experiment showed that the recombinant Nef protein was myristoylated. The recombinant Nef protein was purified to near homogeneity by DEAE-Sephacel, phenyl-Sepharose 4B, blue-Sepharose, and Sephadex G-150 column chromatography. No detectable GTP binding activity was observed in the purified recombinant Nef product.
FEBS Letters | 1998
Chikaya Moriya; Tatsuo Shioda; Kei Tashiro; Takashi Nagasawa; Masaya Ikegawa; Yukano Ohnishi; Atsushi Kato; Huiling Hu; Xiaomi Xin; Mohammad K. Hasan; Midori Maekawa; Yutaka Takebe; Yuko Sakai; Tasuku Honjo; Yoshiyuki Nagai
We describe a robust expression of human stromal cell‐derived factor‐1α (SDF‐1α) and SDF‐1β, the members of CXC‐chemokine family, with a novel vector system based upon Sendai virus, a non‐segmented negative strand RNA virus. Recombinant SDF‐1α and SDF‐1β were detected as a major protein species in culture supernatants, reached as high as 10 μg/ml. This remarkable enrichment of the products allowed us to use even the crude supernatants as the source for biological and antiviral assays without further concentration nor purification and will thus greatly facilitate to screen their genetically engineered derivatives.
Biochemical and Biophysical Research Communications | 1991
Seisuke Hattori; Naoko Ohmi; Midori Maekawa; Masato Hoshino; Masao Kawakita; Shun Nakamura
Cellular fractionation of GTPase activating protein (GAP) activity using bovine cerebral cortex revealed that about half of GAP activity was found in membrane fraction. GAP activity of membrane was not solubilized with 0.5% (v/v) triton X-100 and was immunoprecipitated with antibody against carboxy-terminus of neurofibromatosis type 1 (NF1) gene product. In contrast, soluble GAP activity was precipitated with antibody against GAP but not with anti-NF1. These results suggest that NF1 gene product is a GTPase activating protein toward ras p21 with completely different intracellular distribution from that of GAP.
Science | 1999
Midori Maekawa; Toshimasa Ishizaki; Shuken Boku; Akiko Fujita; Akihiro Iwamatsu; Takashi Obinata; Kazumasa Ohashi; Kensaku Mizuno; Shuh Narumiya
Molecular Pharmacology | 2000
Toshimasa Ishizaki; Masayoshi Uehata; Ichiro Tamechika; Jeongsin Keel; Kimiko Nonomura; Midori Maekawa; Shuh Narumiya
Journal of Cell Biology | 1998
Masaya Hirose; Toshimasa Ishizaki; Masayoshi Uehata; Onno Kranenburg; Wouter H. Moolenaar; Fumio Matsumura; Midori Maekawa; Haruhiko Bito; Shuh Narumiya